publication date: Dec. 18, 2010

In this issue: 

Three NCAB Members Say They Cannot Offer “Strong Endorsement” Of P-4 Trial.

NEJM Papers, Interview With NCI’s Doroshow, Provide Justification For Regulatory Action on ESAs.

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

NCI Funds New Centers At Stanford, Baylor.

Download (PDF 486KB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.